Cover Image
Market Research Report

Europe Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type, By Product, Application, and Geography

Published by The Insight Partners Product code 928780
Published Content info 160 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type, By Product, Application, and Geography
Published: February 21, 2020 Content info: 160 Pages
Description

The Europe cell line development market is expected to reach US$ 3,170.94 Mn in 2027 from US$ 1,207.15 Mn in 2019. The market is estimated to grow with a CAGR of 12.8% from 2020-2027.

Government and private funding for biotechnology research, the launch of innovative technologies for cell line synthesis, and an increase in various research for novel technology-based applications are likely to be the major factors driving the growth of this market in the European region. Europe holds a robust technological base in terms of number of patent filings. This adds up significantly to the high degree of intellectual property rights in the region leading to its strong position in the cell line development market. Also, efforts taken by the National Government to encourage innovation through incentives provision and tax exemption for R&D and new biotech start-ups are expected to favor the growth of the European cell line development market over the forecast years.

Moreover, the companies are performing various activities for the cell line development market, for instance, Selexis, Carestream Avacta, JSR Life Sciences. Has done recent developments for products.

In 2019, the recombinant cell line segment held the most significant market share of the cell line development market, by type. This segment is also anticipated to dominate the market in 2027 owing to its popularity among manufacturers for the production of therapeutic recombinant proteins. The hybridomas segment is anticipated to witness growth at a significant rate during the forecast period.

The Germany cell line development market is dominated by intraoral media and reagent segment in 2019 with a considerable market share, by product. This segment is also predicted to dominate the market in 2027. Also, media and reagent segment is anticipated to witness growth at a significant rate during the forecast period, owing to the increasing research activities in biotechnology sector.

In 2019, the Bioproduction segment held a considerable market share of the cell line development market, by the application. This segment is also predicted to dominate the market in 2027 owing to higher demand of biologics. However, the drug discovery segment is anticipated to witness growth at a significant rate during the forecast period.

Some of the major primary and secondary sources for cell line development included in the report are European Forum for Industrial Biotechnology and the Bioeconomy, Food and Drug Administration and others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00009032

Table of Contents

1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance

2. Europe Cell Line Development Market - Key Takeaways

3. Europe Cell Line Development Market - Market Landscape

  • 3.1 Overview
  • 3.2 Market Segmentation
    • 3.2.1 Europe Cell Line Development Market - By Type
    • 3.2.2 Europe Cell Line Development Market - By Product
    • 3.2.3 Europe Cell Line Development Market - By Application
    • 3.2.4 Europe Cell Line Development Market - By Country
  • 3.3 PEST Analysis
    • 3.3.1 Europe - PEST Analysis

4. Europe Cell Line Development Market- Key Market Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Increasing Regenerative Medicine Development Activities
    • 4.1.2 Rising Incidence of Chronic Diseases
  • 4.2 Key Market Restraints
    • 4.2.1 Risk Associated with Cell Line Contamination
  • 4.3 Key Market Opportunities
    • 4.3.1 The rise in production of biosimilars
  • 4.4 Future Trends
    • 4.4.1 Consistent Research in Drug Discovery Activities
  • 4.5 Impact Analysis

5. Cell Line Development Market - Europe Analysis

  • 5.1 Europe Cell Line Development Market Revenue Forecasts And Analysis
  • 5.2 Market Positioning
  • 5.3 Performance of Key Players
    • 5.3.1 Merck KGaA
    • 5.3.2 Thermo Fisher Scientific Inc.
  • 5.4 Expert Opinions

6. Europe Cell Line Development Market Analysis - By Type

  • 6.1 Overview
  • 6.2 Europe Cell Line Development Market, By Type, 2018 & 2027 (%)
  • 6.3 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • 6.4 Recombinant Cell Line Market
    • 6.4.1 Overview
    • 6.4.2 Europe Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)
  • 6.5 Hybridomas
    • 6.5.1 Overview
    • 6.5.2 Europe Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
  • 6.6 Primary Cell Line
    • 6.6.1 Overview
    • 6.6.2 Europe Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)
  • 6.7 Continuous Cell Lines
    • 6.7.1 Overview
    • 6.7.2 Europe Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)

7. Europe Cell Line Development Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Europe Cell Line Development Market, By Product, 2018 & 2027 (%)
  • 7.3 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • 7.4 Media And Reagent Market
    • 7.4.1 Overview
    • 7.4.2 Europe Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)
  • 7.5 Equipment
    • 7.5.1 Overview
    • 7.5.2 Europe Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

8. Europe Cell Line Development Market Analysis - By Application

  • 8.1 Overview
  • 8.2 Europe Cell Line Development Market, By Application, 2018 & 2027 (%)
  • 8.3 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • 8.4 Bioproduction
    • 8.4.1 Overview
    • 8.4.2 Europe Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)
  • 8.5 Drug Discovery
    • 8.5.1 Overview
    • 8.5.2 Europe Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
  • 8.6 Tissue Engineering
    • 8.6.1 Overview
    • 8.6.2 Europe Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)

9. Europe Cell Line Development Market Revenue And Forecasts To 2027

  • 9.1 Overview

Europe Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

  • 9.2 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • 9.3 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • 9.4 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • 9.5 Europe Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)
  • 9.6 Germany Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
    • 9.6.1 Germany Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.6.2 Germany Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.6.3 Germany Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.6.4 Germany Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.7 UK Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
    • 9.7.1 UK Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.7.2 UK Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.7.3 UK Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.7.4 UK Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.8 France Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
    • 9.8.1 France Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.8.2 France Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.8.3 France Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.8.4 France Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.9 Spain Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
    • 9.9.1 Spain Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.9.2 Spain Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.9.3 Spain Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.9.4 Spain Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 9.10 Italy Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
    • 9.10.1 Italy Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.10.2 Italy Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.10.3 Italy Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
    • 9.10.4 Italy Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10. Cell Line Development Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The Cell Line Development Market, (%)
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies in the Cell Line Development Market, 2016-2019
    • 10.3.3 Expansion
      • 10.3.3.1 Recent Expansion By Players in The Cell Line Development Market
    • 10.3.4 Inorganic Developments
    • 10.3.5 Overview
    • 10.3.6 Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019
    • 10.3.7 Agreements
      • 10.3.7.1 The Cell Line Development Market, By Agreements
    • 10.3.8 Acquisitions
      • 10.3.8.1 Acquisitions By Players in the Cell Line Development Market

Source: The Insight Partners Analysis

11. Cell Line Development Market-Key Company Profiles

  • 11.1 Merck KGaA
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Thermo Fisher Scientific, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Information
    • 11.2.4 Product /Services Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Sartorius AG
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Selexis
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product/Service Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Biofactura, Inc.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Wuxi AppTec
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Overview
    • 11.6.4 Service Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 LakePharma, Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 General Electric
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Lonza
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Information
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Corning Incorporated
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary Of Terms
  • 12.3 Methodology
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research

LIST OF TABLES

  • Table 1. Europe Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 2. Europe Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 3. Europe Cell line development market Revenue And Forecasts to 2027, By Applicayion (US$ Mn)
  • Table 4. Europe Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 5. Europe Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 6. Europe Cell line development market Revenue And Forecasts to 2027, By application (US$ Mn)
  • Table 7. Germany Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 8. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. UK Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 11. UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 12. UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 13. France Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 14. France Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 15. France Cell line development market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 16. Spain Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 17. Spain Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 18. Spain Cell line development market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 19. Italy Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 20. Italy Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)
  • Table 21. Italy Cell line development market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 22. Recent Expansion in The Cell Line Development Market
  • Table 23. The Cell Line Development Market by Agreements
  • Table 24. Acquisitions in the Cell Line Development Market
  • Table 25. Glossary of Terms, Cell Line Development Market

LIST OF FIGURES

  • Figure 1. Germany Cell Line Development Market, Revenue (US$ Mn), By 2018 & 2027
  • Figure 2. Europe Cell Line Development Market By Type Market Share (%), 2018
  • Figure 3. Europe Cell Line Development Market By Product Market Share (%), 2018
  • Figure 4. Europe Cell Line Development Market By Application Market Share (%), 2018
  • Figure 5. Cell Line Development Market Segmentation
  • Figure 6. Europe PEST Analysis
  • Figure 7. Cell Line Development Market Impact Analysis Of Drivers & Restraints
  • Figure 8. Europe Cell Line Development Market - Revenue Forecasts And Analysis - 2018- 2027
  • Figure 9. Europe Cell Line Development Market, By Type, 2018 & 2027 (%)
  • Figure 10. Europe Recombinant Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 11. Europe Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 12. Europe Primary Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 13. Europe Continuous Cell Lines Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 14. Europe Cell Line Development Market, By Product, 2018 & 2027 (%)
  • Figure 15. Europe Media And Reagent Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 16. Europe Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 17. Europe Cell Line Development Market, By Application, 2018 & 2027 (%)
  • Figure 18. Europe Bioproduction Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Europe Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. Europe Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 21. Europe Cell Line Development Market Revenue, By Country, 2018 (US$ Mn)
  • Figure 22. Europe Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Europe Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 24. Germany Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 25. UK Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 26. France Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Spain Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Italy Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. Growth Strategies in The Cell Line Development Market, (%)
  • Figure 30. Organic Growth Strategies In The Cell Line Development Market, 2016-2019
  • Figure 31. Inorganic Developments In The Cell Line Development Market, 2016-2019
Back to Top